BUSINESS COMBINATIONS - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions							12 Months Ended
	Oct. 01, 2024	Sep. 30, 2024	Aug. 19, 2024	Aug. 18, 2024	Jul. 22, 2024	Feb. 28, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Goodwill							$ 1,776.7	$ 1,145.1	$ 1,064.8
Payment for acquisition options							$ 46.2	$ 30.0	$ 109.6
Innovalve Bio Medical Limited
Business Acquisition [Line Items]
Cash consideration paid at closing	$ 319.3	$ 30.0
Settlement of pre-existing relationships	5.4
Fair value of previously held equity interest	64.6	$ 3.5
Fair value of contingent consideration	12.7
Total purchase price	402.0
Less: cash acquired	(21.1)
Total purchase price, net of cash acquired	380.9
Current assets	26.5
Property and equipment, net	1.2
Goodwill	205.4
Liabilities assumed	(8.2)
Deferred tax liabilities	(41.3)
Fair value of net assets acquired	402.0
Total purchase price, net of cash acquired	$ 298.2
Innovalve Bio Medical Limited | In-process research and development
Business Acquisition [Line Items]
Intangibles			$ 218.4
Endotronix, Inc
Business Acquisition [Line Items]
Cash consideration paid at closing			650.3	$ 60.0
Settlement of pre-existing relationships			53.1
Fair value of previously held equity interest			94.6	$ 10.0
Fair value of contingent consideration			2.0
Total purchase price			800.0
Less: cash acquired			(1.2)
Total purchase price, net of cash acquired			798.8
Current assets			7.7
Property and equipment, net			12.6
Goodwill			382.8
Operating lease right-of-use assets			9.9
Other assets			0.7
Liabilities assumed			(26.3)
Deferred tax liabilities			(45.2)
Fair value of net assets acquired			800.0
Total purchase price, net of cash acquired			649.1
Endotronix, Inc | In-process research and development
Business Acquisition [Line Items]
Intangibles			68.9
Endotronix, Inc | Developed technology
Business Acquisition [Line Items]
Intangibles			$ 388.9
JC Medical, Inc.
Business Acquisition [Line Items]
Cash consideration paid at closing					$ 114.8
Fair value of contingent consideration					1.8
Total purchase price					116.6
Less: cash acquired					(0.3)
Total purchase price, net of cash acquired					116.3
Current assets					0.3
Property and equipment, net					0.3
Goodwill					46.4
Current liabilities assumed					(1.0)
Deferred tax liabilities					(16.0)
Fair value of net assets acquired					116.6
JC Medical, Inc. | In-process research and development
Business Acquisition [Line Items]
Intangibles					$ 86.6
Medical Technology Company | Variable Interest Entity, Primary Beneficiary
Business Acquisition [Line Items]
Less: cash acquired						$ (6.8)
Current assets						8.1
Goodwill						133.2
Intangibles						136.6
Current liabilities assumed						(1.7)
Deferred tax liabilities						(28.0)
Fair value of net assets acquired						248.2
Less: Noncontrolling interest						(72.4)
Total purchase price						175.8
Total purchase price, net of cash acquired						169.0
Noncontrolling interest, gross						94.4
Payment for option to acquire company						22.0
Payment for acquisition options						22.5
Repayments of pre-existing notes						5.3
Cash paid directly to acquired company, netted against goodwill						$ 46.0